SCHEMBL18758237

SCHEMBL18758237

Cc1ccc(-c2nnc(SCCCCl)n2C)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.76
RAB9A P51151 3/20 0.76
MEN1 O00255 2/20 0.76
CYP2C19 P33261 2/20 0.76
KMT2A Q03164 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
CYP1A2 P05177 1/20 0.76
HTT P42858 1/20 0.76
MAPT P10636 5/20 0.61
HPGD P15428 2/20 0.61
ALDH1A1 P00352 2/20 0.61
DRD2 P14416 5/20 0.55
HDAC3 O15379 2/20 0.53
PTK2 Q05397 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
HDAC1 Q13547 1/20 0.53
DRD3 P35462 4/20 0.52
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20840889 0.89 NPC1 (0.60) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL4385569 0.88 DRD2 (0.71) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL17712729 0.87 HDAC3 (0.69) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL4199664 0.87 NPC1 (1.00) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL18758357 0.86 NPC1 (0.58) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL17713086 0.85 NPC1 (0.56) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL379199 0.85 NPC1 (0.56) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL17712975 0.85 NPC1 (0.56) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL17713006 0.84 NPC1 (0.55) NPC1RAB9AMEN1CYP2C19KMT2A
SCHEMBL17712844 0.84 HPGD (0.58) NPC1RAB9AMEN1CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017064488-A1 DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY INDIVIOR UK LIMITED (GB) 2017-04-20 WO disclosed